PLYX · Polaryx Therapeutics, Inc.
$2.01
-0.05 (-2.43%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, along with the conditions described above, raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$102.68M
Shares
49.85M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-13 | 2,391 | $2.23 | $5,332 |
| 2026-08-11 | 857 | $2.12 | $1,817 |
| 2026-08-10 | 60 | $2.26 | $136 |
| 2026-08-07 | 5 | $2.22 | $11 |
| 2026-08-06 | 3,608 | $2.24 | $8,082 |
| 2026-08-05 | 3,208 | $2.23 | $7,154 |
| 2026-08-03 | 2,152 | $2.31 | $4,971 |
| 2026-07-31 | 5,524 | $2.15 | $11,877 |
| 2026-07-29 | 8,644 | $1.99 | $17,202 |
| 2026-07-24 | 2,888 | $2.11 | $6,094 |
| 2026-07-22 | 883 | $2.32 | $2,049 |
| 2026-07-20 | 134 | $2.28 | $306 |
| 2026-07-15 | 2,034 | $2.26 | $4,597 |
| 2026-07-14 | 6,803 | $2.20 | $14,967 |
| 2026-07-08 | 301 | $2.53 | $762 |
| 2026-07-02 | 32,186 | $2.58 | $83,040 |
| 2026-07-01 | 34,961 | $2.66 | $92,996 |
| 2026-06-30 | 44,428 | $2.53 | $112,403 |
| 2026-06-26 | 1,700 | $2.31 | $3,927 |
| 2026-06-23 | 3,204 | $2.41 | $7,722 |
| 2026-06-22 | 10,870 | $2.32 | $25,218 |
| 2026-06-10 | 3,252 | $2.28 | $7,415 |
| 2026-06-09 | 14,644 | $2.46 | $36,024 |
| 2026-06-05 | 1,336 | $2.53 | $3,380 |
| 2026-06-04 | 37,016 | $2.52 | $93,280 |
| 2026-06-03 | 43,454 | $2.64 | $114,719 |
Showing 1–26 of 26 settlements
Key facts
CIK
2075320
CUSIP
73110F100
13F (30d)
12 filings
12 filers
Visit website
Investor relations